全文获取类型
收费全文 | 10590篇 |
免费 | 607篇 |
国内免费 | 124篇 |
专业分类
耳鼻咽喉 | 124篇 |
儿科学 | 287篇 |
妇产科学 | 201篇 |
基础医学 | 1129篇 |
口腔科学 | 286篇 |
临床医学 | 856篇 |
内科学 | 3272篇 |
皮肤病学 | 151篇 |
神经病学 | 960篇 |
特种医学 | 374篇 |
外科学 | 1682篇 |
综合类 | 21篇 |
一般理论 | 1篇 |
预防医学 | 389篇 |
眼科学 | 80篇 |
药学 | 610篇 |
中国医学 | 32篇 |
肿瘤学 | 866篇 |
出版年
2023年 | 153篇 |
2022年 | 263篇 |
2021年 | 554篇 |
2020年 | 328篇 |
2019年 | 391篇 |
2018年 | 431篇 |
2017年 | 315篇 |
2016年 | 371篇 |
2015年 | 385篇 |
2014年 | 538篇 |
2013年 | 567篇 |
2012年 | 831篇 |
2011年 | 771篇 |
2010年 | 420篇 |
2009年 | 406篇 |
2008年 | 606篇 |
2007年 | 567篇 |
2006年 | 549篇 |
2005年 | 454篇 |
2004年 | 381篇 |
2003年 | 327篇 |
2002年 | 287篇 |
2001年 | 150篇 |
2000年 | 168篇 |
1999年 | 138篇 |
1998年 | 58篇 |
1997年 | 36篇 |
1996年 | 37篇 |
1995年 | 33篇 |
1994年 | 38篇 |
1993年 | 24篇 |
1992年 | 63篇 |
1991年 | 59篇 |
1990年 | 60篇 |
1989年 | 53篇 |
1988年 | 62篇 |
1987年 | 51篇 |
1986年 | 43篇 |
1985年 | 50篇 |
1984年 | 34篇 |
1983年 | 19篇 |
1981年 | 14篇 |
1979年 | 25篇 |
1978年 | 17篇 |
1977年 | 13篇 |
1976年 | 13篇 |
1974年 | 21篇 |
1972年 | 17篇 |
1971年 | 16篇 |
1969年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 296 毫秒
21.
Fungal infections in cancer patients: An international autopsy survey 总被引:33,自引:0,他引:33
G. Bodey B. Bueltmann W. Duguid D. Gibbs H. Hanak M. Hotchi G. Mall P. Martino F. Meunier S. Milliken S. Naoe M. Okudaira D. Scevola J. van't Wout 《European journal of clinical microbiology & infectious diseases》1992,11(2):99-109
In an attempt to estimate the frequency of fungal infections among cancer patients, a survey of autopsy examinations was conducted in multiple institutions in Europe, Japan and Canada. Fungal infections were identified most often in leukemic patients and transplant recipients (25 % each). Fifty-eight percent of fungal infections were caused byCandida spp. and 30 % byAspergillus spp. There was considerable variability in the frequency of fungal infections in different countries. Nevertheless, this study clearly demonstrates that fungal infections represent a common complication in cancer patients, especially in patients with leukemia. 相似文献
22.
23.
B G Redman L Flaherty S Martino M Kraut C Wisniewski M Valdivieso J J Bander 《American journal of clinical oncology》1992,15(4):340-343
Administration of high-dose IL-2 results in hemodynamic changes that are similar to those seen in septic shock. These include a decrease in systemic vascular resistance (SVR) with a resultant drop in mean arterial pressure (MAP). Hypocalcemia is seen in septic shock and with IL-2 administration. Calcium replacement in septic shock has been reported to result in hemodynamic improvement; we therefore administered calcium to patients receiving high dose IL-2 to correct ionized hypocalcemia. Five consecutive patients underwent invasive hemodynamic monitoring before and during IL-2 administration. Calcium chloride was administered to correct ionized hypocalcemia, and hemodynamic parameters were monitored before and after calcium administration. Ionized hypocalcemia was associated with an elevation in parathyroid hormone levels. There was no toxicity related to the administration of calcium. An improvement in the MAP and SVR was seen early and late (after a dose of IL-2 was held) in the IL-2 treatment cycle; there were minimal effects at other points. Because of the potential hemodynamic benefit of calcium replacement, we recommend that ionized hypocalcemia be corrected in patients receiving high-dose IL-2. 相似文献
24.
Livio Presutti Matteo Alicandri Ciufelli Daniele Marchioni Domenico Villari Alessio Marchetti Francesco Mattioli 《Otolaryngology--head and neck surgery》2007,136(3):369-372
OBJECTIVE: The aim of this paper was to describe our surgical technique for the treatment of nasal septal perforations. STUDY AND DESIGN: We studied 31 patients with nasal septal perforation treated with an endoscope-assisted technique, based on a bilateral dissection of monopedicled mucosal flaps from the nasal fossa floor, sutured at the edge of the perforation previously unstuck, without any graft interposed between the two mucosal layers. RESULTS: In our experience with 31 patients, the use of this technique led to the persistent closing (with follow-up for at least one year) of 96.3% of the perforations smaller than 3 cm. CONCLUSIONS: Our technique has the advantage of an endonasal approach, without any external incision, and the use of monopedicled flaps from the nasal fossa floor without any graft interposition, avoiding any other surgical procedure and morbidity in the donor site of the graft. The use of nasal endoscopy permits superior precision in all surgical steps. SIGNIFICANCE: The high success rate in perforations smaller than 3 cm seems to confirm the effectiveness of this technique. 相似文献
25.
Kees-Peter De Roos MD Fred H.M. Nieman PHD H.A. Martino Neumann MD PHD 《Dermatologic surgery》2003,29(3):221-226
BACKGROUND: Although no randomized controlled trial has assessed the effects of either compression sclerotherapy or ambulatory phlebectomy, both techniques are used to treat varicose veins worldwide. We performed a randomized controlled trial to compare recurrence rates of varicose veins and complications after compression sclerotherapy and ambulatory phlebectomy. METHODS: From September 1996 to October 1998, we randomly allocated 49 legs to compression sclerotherapy and 49 legs to ambulatory phlebectomy. Our primary outcome parameters were as follows: recurrence rates at 1 and 2 years and complications related to therapy. Eighty-two patients were included, of whom 16 were included with both of their legs. The number of treated legs was therefore 98, but two patients were lost to follow-up. RESULTS: One year recurrence amounted to 1 out of 48 for phlebectomy and 12 out of 48 for compression sclerotherapy (P<0.001); at 2 years, six additional recurrences were found, but then solely for compression sclerotherapy (P<0.001). Significant differences in complications occurring more in phlebectomy than in compression sclerotherapy therapy were blisters, teleangiectatic matting, scar formation, and bruising from bandaging. CONCLUSION: Our results show that ambulatory phlebectomy is an effective therapy for varicose veins of the leg. Recurrence rates are significantly lower than for compression sclerotherapy therapy. If varicose veins persist 4 weeks after compression sclerotherapy, it can be argued that to reduce the risk of future recurrence ambulatory phlebectomy should be considered as the better treatment option. 相似文献
26.
Paolo Cossu Rocca Matteo Brunelli Stefano Gobbo Albino Eccher Emma Bragantini Maria M Mina Vincenzo Ficarra Filiberto Zattoni Alberto Zamò Maurizio Pea Aldo Scarpa Marco Chilosi Fabio Menestrina Franco Bonetti John N Eble Guido Martignoni 《Modern pathology》2007,20(7):722-728
S100A1 is a calcium-binding protein, which has been recently found in renal cell neoplasms. We evaluated the diagnostic utility of immunohistochemical detection of S100A1 in 164 renal cell neoplasms. Forty-one clear cell, 32 papillary, and 51 chromophobe renal cell carcinomas, and 40 oncocytomas, 164 samples of normal renal parenchyma adjacent to the tumors and 13 fetal kidneys were analyzed. The levels of S100A1 mRNA detected by quantitative RT-PCR analysis of frozen tissues from seven clear cell, five papillary, and six chromophobe renal cell carcinomas, four oncocytomas, and nine samples of normal renal tissues adjacent to neoplasms were compared with the immunohistochemical detection of protein expression. Clear cell and papillary renal cell carcinomas showed positive reactions for S100A1 in 30 out of 41 tumors (73%) and in 30 out of 32 (94%) tumors, respectively. Thirty-seven renal oncocytomas out of 40 (93%) were positive for S100A1, whereas 48 of 51 (94%) chromophobe renal cell carcinomas were negative. S100A1 protein was detected in all samples of unaffected and fetal kidneys. S100A1 mRNA was detected by RT-PCR in all normal kidneys and renal cell neoplasms, although at very different levels. Statistical analyses comparing the different expression of S100A1 in clear cell and chromophobe renal cell carcinomas observed by immunohistochemical and RT-PCR methods showed significant values (P<0.001), such as when comparing by both techniques the different levels of S100A1 expression in chromophobe renal cell carcinomas and oncocytomas (P<0.001). Our study shows that S100A1 protein is expressed in oncocytomas, clear cell and papillary renal cell carcinomas but not in chromophobe renal cell carcinomas. Its immunodetection is potentially useful for the differential diagnosis between chromophobe renal cell carcinoma and oncocytoma. Further, S100A1 protein expression is constantly detected in the normal parenchyma of the adult and fetal kidney. 相似文献
27.
M de Martino M Resti C Appendino A Vierucci 《Journal of pediatric gastroenterology and nutrition》1987,6(2):208-211
Antibody response to hepatitis B virus vaccine was compared in 47 breast- and 112 formula-fed infants born to hepatitis B surface antigen-(HBsAg-) positive mothers. No difference was observed as to the percentage of infants who seroconverted. However, formula-fed infants developed transient but significantly higher anti-HBs antibody levels as compared to breast-fed infants. Suppressive factors in human milk or orally induced tolerance may explain this finding. The latter hypothesis may be supported by the presence of HBsAg in more than half of the milk samples we studied. 相似文献
28.
A number of substituted 2-[(2,2,2-trifluoroethyl)sulfonyl]-1H-benzimidazoles (4) have demonstrated antiinflammatory activity that appears to have a mechanism distinct from typical cyclooxygenase inhibiting nonsteroidal antiinflammatory drugs. Several of these compounds inhibit adjuvant-induced arthritis in rats at 25 mg/kg while showing no activity in the carrageenan paw edema model at up to 100 mg/kg. Two compounds, 4a and 4b, showed no significant inhibition of cyclooxygenase in vitro at concentrations as high as 5 X 10(-5) M. All compounds 4 active in adjuvant-induced arthritis were also found to inhibit release of lysosomal enzymes from neutrophils, raising the possibility that their antiinflammatory effect is at least partially mediated by an effect on neutrophil function. 相似文献
29.
E. Novembre F. Mori N. Pucci R. Bernardini A. Vierucci M. de Martino 《Pediatric allergy and immunology》2007,18(S18):56-61
Systemic acute rhinosinusitis therapy consists mostly of antibiotic treatment because pathogens play a major role. Amoxicillin is the drug of choice for treatment of acute rhinosinusitis, with second- and third- generation cephalosporins, azythromycin, clarithromycin, and telithromycin as possible options, especially in the case of allergy to amoxicillin. If the clinical course suggests that an anaerobic pathogen is more likely, clindamycin or metronidazole can be considered in combination with a broad-spectrum drug. In antimicrobial treatment of chronic sinusitis there is no consensus on treatment length, organism coverage, or which antibiotics are most effective because the bacteriology is variable with polymicrobial anaerobic and aerobic organisms present. Adjuvant therapies need to be proven by additional studies. Chronic rhinosinusitis is heterogeneous and treatment should vary according to the causative factor involved. Short courses of systemic steroids have been found very useful to decrease mucosal swelling and inflammation in chronic rhinosinusitis. However, no randomized controlled studies have been performed to validate their efficacy in children. A variety of other agents are used in the treatment of chronic rhinosinusitis including antihistamines, decongestants, and leukotriene modifiers. To date, there is no good evidence from randomized controlled studies to support the use of any of these agents in the treatment of this disease in either children or adults. 相似文献
30.